34
Participants
Start Date
September 1, 2025
Primary Completion Date
September 1, 2027
Study Completion Date
September 1, 2028
Cabozantinib
For patients using 40mg the experimental regimen consists of 60mg once daily for 2 days followed by 1 skipping day (60-60-0 mg). For patients using 20mg the experimental regimen consists of 60mg once daily for 1 day followed by 2 skipping days (60-0-0 mg).
dr. Tom van der Hulle
OTHER